Similar articles

• Actinic keratosis: facts and controversies.

  Ko CJ. Ko CJ. Clin Dermatol. 2010 May-Jun;28(3):249-53. doi: 10.1016/j.clindermatol.2009.06.009. Clin Dermatol. 2010. PMID: 20541675
• Prospective comparison of three guideline development methods for treatment of actinic keratosis.

  Borgonjen RJ, van Everdingen JJ, Bik CM, Tuut MK, Spuls PI, van de Kerkhof PC. Borgonjen RJ, et al. BMJ Qual Saf. 2011 Oct;20(10):832-41. doi: 10.1136/bmjqs.2010.050443. Epub 2011 May 26. BMJ Qual Saf. 2011. PMID: 21617167
• Commentary on the "Evidence- and Consensus-Based (S3) Guidelines for the Treatment of Actinic Keratosis" Published by the International League of Dermatological Societies in Cooperation with the European Dermatology Forum.

  Diepgen TL, Kresken J, Krutmann J, Merk HF, Senger E, Surber C, Szeimies RM; GD Task Force "Licht.Hautkrebs.Prävention" of the Society for Dermopharmacy. Diepgen TL, et al. Skin Pharmacol Physiol. 2018;31(3):144-146. doi: 10.1159/000486687. Epub 2018 Apr 3. Skin Pharmacol Physiol. 2018. PMID: 29614495
• Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference.

  Del Rosso JQ. Del Rosso JQ. Cutis. 2011 Jul;88(1):suppl 1-8. Cutis. 2011. PMID: 21877505 Review.
• Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.

  Werner RN, Jacobs A, Rosumeck S, Erdmann R, Sporbeck B, Nast A. Werner RN, et al. J Eur Acad Dermatol Venereol. 2015 Nov;29(11):e1-66. doi: 10.1111/jdv.13179. Epub 2015 Sep 9. J Eur Acad Dermatol Venereol. 2015. PMID: 26350885 No abstract available.